Evidence map›Paper›PMID 42443598›Full record

ArticleNature chemical biology2026

Proteoform-specific enrichment of phosphopeptide isomers by polymer-based synthetic receptors.

Anıl İncel, Sudhirkumar Shinde, Ignacio Arribas Díez, Maria M Stollenwerk, Jingjing Xu, Tina Ravnsborg, Magnus E Jakobsson, Ole N Jensen, Börje Sellergren

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anıl İncel *Biofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden. anil.incel@mau.se.ORCID http://orcid.org/0000-0003-1723-9803
Sudhirkumar Shinde *Biofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.ORCID http://orcid.org/0000-0001-9460-0936
Ignacio Arribas DíezDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.ORCID http://orcid.org/0000-0001-7064-5283
Maria M StollenwerkBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
Jingjing XuDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Tina RavnsborgDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.ORCID http://orcid.org/0000-0002-6376-621X
Magnus E JakobssonBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
Ole N JensenDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark. jenseno@bmb.sdu.dk.ORCID http://orcid.org/0000-0003-1862-8528
Börje SellergrenBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden. borje.sellergren@mau.se.ORCID http://orcid.org/0000-0002-2392-3305

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) Se 777/9-1EC | EC Seventh Framework Programm | FP7 People: Marie-Curie Actions (FP7-PEOPLE - Specific Programme "People" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) PITN-GA-2010-264699EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) H2020-MSCA-ITN-2016, 722171Vetenskapsrådet (Swedish Research Council) 2021-04655Villum Fonden (Villum Foundation) 7292
6 · The paper itself

Abstract

Site-level resolution of protein phosphorylation remains a central challenge in decoding cellular signaling and conventional global phosphoproteomics is limited in its ability to detect low-abundance peptides and resolve positional isomers. Here we introduce sequence-selective synthetic receptors based on imprinted polymers for targeted enrichment of defined phosphopeptide motifs from complex cancer cell proteomes. By encoding local sequence context into the binding interface, these receptors enable selective capture of closely related phosphorylation sites with high specificity. Using the T cell kinase ZAP70 as a model, we resolve phosphorylation at adjacent tyrosine residues (pY492 and pY493) within a regulatory motif, overcoming a long-standing limitation in site discrimination. Integrated with liquid chromatography-mass spectrometry workflows, this enables sensitive detection of low-abundance and isomeric phosphopeptides that evade conventional enrichment strategies. More broadly, our findings establish molecular imprinting as a programmable chemical platform for site-resolved phosphoproteomics, opening new avenues to interrogate signaling networks with molecular precision.

Indexed as

PhosphopeptidesPolymersProteomicsAmino Acid SequenceHumansIsomerismMass SpectrometryMolecular ImprintingPhosphorylationZAP-70 Protein-Tyrosine KinasePhosphopeptidesPolymersZAP-70 Protein-Tyrosine Kinase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.